BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kunanopparat A, Issara-Amphorn J, Leelahavanichkul A, Sanpavat A, Patumraj S, Tangkijvanich P, Palaga T, Hirankarn N. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication. World J Gastroenterol 2018; 24(34): 3861-3870 [PMID: 30228780 DOI: 10.3748/wjg.v24.i34.3861]
URL: https://www.wjgnet.com/1007-9327/full/v24/i34/3861.htm
Number Citing Articles
1
I. S. Karlina, E. S. Gorozhanina, I. V. Ulasov. THE PROSPECT OF USING ONCOGENES’ INHA, DLL4 AND MMP2 ROLE IN DIAGNOSIS AND TREATMENT OF ONCOLOGICAL DISEASERussian Journal of Biotherapy 2021; 20(1): 8 doi: 10.17650/1726-9784-2021-20-1-8-15
2
Vinit Singh Baghel, Sapnita Shinde, Vineeta Dixit, Naveen Kumar Vishvakarma, Atul Kumar Tiwari, Soumitra Tiwari, Dhananjay Shukla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 337 doi: 10.1016/B978-0-323-98807-0.00009-0
3
Meng-Xi Xiu, Yuan-Meng Liu, Bo-hai Kuang. <p>The Role of DLLs in Cancer: A Novel Therapeutic Target</p>OncoTargets and Therapy 2020; : 3881 doi: 10.2147/OTT.S244860
4
Hongbo Wang, Fang Chu, Li Zhijie, Qian Bi, Li Lixin, Yunlong Zhuang, Zhang Xiaofeng, Xiaofeng Niu, Dali Zhang, He Xi, Bo-an Li. MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cellsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.985082
5
Yuqi Fan, Zhe Ma, LuLu Zhao, Wei Wang, Mengyuan Gao, Xiaohua Jia, Huizi Ouyang, Jun He. Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A reviewBiomedicine & Pharmacotherapy 2020; 132: 110820 doi: 10.1016/j.biopha.2020.110820